David Zidar, MD

Showing    of 1 results

Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients

Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018  David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...

Read More

Results are loading...